Mobile consumer ECG maker AliveCor announced today that its long-teased six-lead ECG device has been cleared by the FDA and will be available to customers in June of this year. “[The KardiaMobile 6L ...

Mountainview, CA-based AliveCor, a developer of ECG software that can be integrated with wearable devices, has had a week full of highs and lows. On one hand, the company secured FDA clearance for the ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

Please provide your email address to receive an email when new articles are posted on . AliveCor announced the FDA clearance and launch of its AI for ECG interpretation and streamlined, handheld ECG ...

Apple may be moving towards commoditizing the on-the-wrist ECG, but other companies in the space aren’t resting on their laurels. AliveCor, which has offered an smartphone-connected ECG since 2012 and ...

When AliveCor launched in 2011, it had a simple mission: Empower people to take control of their heart health. It did that by disrupting the field of cardiology and designing a Food and Drug ...

US-based AliveCor has received US Food and Drug Administration (FDA) approval for the next generation of its KAI 12L artificial intelligence (AI), powering the Kardia 12L ECG System. This update ...

The Kardia 12L, which uses five electrodes and a single cable to replace bulky 10-lead ECG carts, has received CE Mark. It launches first in France, Germany, Italy, Spain, and the UK, with its AI ...